Guidelines
The Danish Drug Administration has published a guideline to doctors who want to prescribe cannabis. It is available here. (Danish only)
To support a further need for guidance in prescriptions and dosage, we have gathered material from Health Administrations in other countries, who have legalized cannabis for medicinal use.
Below are guidelines from Australia and Canada as well as other relevant material and links about interactions, adverse effects and research evidence.
We will update the guidelines when necessary.
Whitepapers fra ICCI.science (International Cannabis and Cannabinoids Institute, Czech Rep.)
Introduction to the Endocannabinoid System (2019) by Ethan Russo, MD, ICCI Research & Development Director
Pharmacodynamics of Cannabinoids (2019) by Prof. MUDr. Alexandra Šulcová, CSc., FCMA, FECNP, FCINP
Cannabidiol (CBD) and Hemp: Novel Food Status in the EU. (2018) by Martin Másílko, Tomáš Sadílek, Teresa Martin and Erik Jurado
All papers are available here: https://www.icci.science/en/cannabis-cannabinoids-education/cannabis-cannabinoids-whitepapers
Practical considerations in medical cannabis administration and dosing
Artikle from European Journal of Internal Medicine
Guidelines from Australia
Guidelines from Canada
Guidelines from Queensland, Australia
Adverse effects and interactions
Cannabinoid Drug Interactions (klik på billedet)
Evidence collection
Lectures from CannX 2018
- Nadav Eyal, speaking on “Eybna Technologies on Bio-control Program in Cannabis” here.
- Adi Aran speaking on cannabis for medicinal use for children with autism here.
- Moving lecture on Canadian veterans suffering from PTSD, who have been treated with cannabis here.
- David Meiri speaks about “The Science Behind the Entourage Effect” her.
- Prof. Donald Abrams CannX 2018 on cancer studies here.